首页> 外文期刊>Global Journal of Health Science >Effect of Streptokinase on Reperfusion After Acute Myocardial Infarction and Its Complications: An Ex-Post Facto Study
【24h】

Effect of Streptokinase on Reperfusion After Acute Myocardial Infarction and Its Complications: An Ex-Post Facto Study

机译:链激酶对急性心肌梗死及其并发症后再灌注的影响:一项事后研究

获取原文
           

摘要

INTRODUCTION: Emergency treatment of patients with acute myocardial infarction is very important. Streptokinase in Iran is often as the only clot-busting medication is used. The purpose of using streptokinase medication is to revive the ischemic heart tissue, although has dangerous complications too. Therefore, the present study aimed to determine the effect of streptokinase on reperfusion after acute myocardial infarction and its complications, has been designed and conducted. MATERIALS AND METHODS: This is an Ex-post facto study. The study population included patients who suffer from acute myocardial infarction. The sample size was 300 patients, and 2 groups were matched, in variables of age, sex, underlying disease, frequencies and area of MI. Data collection did by researcher making questionnaire, that accept face and content validity by 10 expert researcher, the reliability was conducted with Spearman’s test (r=0.85) by Test-retest method. Data analysis did by SPSS software: V 12. FINDINGS: Mean of EF in SK group was (46.15±8.11) and in control group was (43.11±12.57). Significant relationship was seen between SK, arrhythmia occurring and improve EF reperfusion by chi-square test (p=0.028), (p=0.020).The most arrhythmia in SK group was Ventricular Tachycardia (20.7%). Significant statistical relation between SK and mortality were found by Chi-square test (p=0.001). But a meaningful statistical relation was not found between SK and pulmonary edema incidence (p=0.071). CONCLUSIONS: Nurses of CCU should be aware about SK complications such as hypotension, bleeding and arrhythmias. Proposed compare SK and tissue plasminogen drug in reperfusion and complications effect.
机译:简介:急性心肌梗死患者的紧急治疗非常重要。在伊朗,链激酶通常是唯一使用的清除血栓的药物。使用链激酶的药物的目的是使缺血性心脏组织恢复活力,尽管它也具有危险的并发症。因此,本研究旨在确定链激酶在急性心肌梗死及其并发症中对再灌注的影响。材料与方法:这是事后研究。研究人群包括患有急性心肌梗塞的患者。样本量为300例患者,按年龄,性别,潜在疾病,MI的发生频率和面积各分为2组。数据收集由研究人员进行问卷调查,接受10位专家研究人员的面部和内容有效性,可靠性通过Spearman检验(r = 0.85)通过重测法进行。用SPSS软件进行数据分析:V 12.结果:SK组的EF平均值为(46.15±8.11),对照组为EF平均值(43.11±12.57)。卡方检验显示,SK与心律失常之间存在显着相关性,并改善EF再灌注(p = 0.028)(p = 0.020)。SK组心律失常最多的是室性心动过速(20.7%)。卡方检验发现SK与死亡率之间存在显着的统计学关系(p = 0.001)。但是在SK和肺水肿发生率之间未发现有意义的统计关系(p = 0.071)。结论:CCU的护士应注意SK并发症,例如低血压,出血和心律不齐。建议比较SK和组织纤溶酶原药在再灌注和并发症中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号